Cord Blood Registry
Private newborn stem cell biobank that collects, processes, cryopreserves, and stores cord blood and cord tissue for long-term family access. Operates a large laboratory and storage facility in Tucson, Arizona; maintains regulatory registrations and external accreditations; supports institutional partnerships and supply of banked units to FDA-regulated clinical trials and academic treatment centers; and offers optional pediatric genetic screening and pharmacogenetic reporting through external CLIA-certified laboratories. Publishes a public registry of released units with structured clinical metadata documenting collecting hospital state (including selected international locations), treatment facility, medical condition and category, year of release, recipient relationship/age, and sample time in storage. The public registry contains entries dated from 2005 through 2025.
Industries
Nr. of Employees
large (251-1000)
Cord Blood Registry
Products
Temperature-protected cord blood and tissue collection kit
Crush-resistant, temperature-protected collection kit with unique barcode identification for collection and transport of cord blood and optional cord tissue; compatible with multiple birth settings and coordinated courier pickup.
At-home buccal swab genetic test kit (mail-in)
Sterile cheek swab kit for at-home pediatric DNA collection including activation code, instructions, and pre-paid return shipping for analysis by external CLIA/CAP-certified laboratory partners.
Temperature-protected cord blood and tissue collection kit
Crush-resistant, temperature-protected collection kit with unique barcode identification for collection and transport of cord blood and optional cord tissue; compatible with multiple birth settings and coordinated courier pickup.
At-home buccal swab genetic test kit (mail-in)
Sterile cheek swab kit for at-home pediatric DNA collection including activation code, instructions, and pre-paid return shipping for analysis by external CLIA/CAP-certified laboratory partners.
Services
Collection, automated processing, and long-term cryopreservation of newborn cord blood for exclusive family access, with multiple storage-term and payment options and client web-portal account management.
Collection and cryopreservation of cord tissue segments to preserve mesenchymal and other progenitor cell types, including pre-storage viability assessment and integrated storage management with cord blood units.
Optional tiered pediatric genetic testing add-on using mailed buccal swab kits and external CLIA/CAP-certified laboratory analysis. Test tiers provide increasing gene-panel breadth (approximately 250, 600, and 1,500+ genes) and the most comprehensive tier includes pharmacogenetic reporting for 125+ medications. Workflow includes kit activation, portal-based tracking, laboratory sequencing and analysis, and portal delivery of clinical reports; clinical-team support is available for result questions.
Program providing no-cost processing and defined-term storage for families who qualify due to an immediate medical need for a related family member, with operational support for urgent clinical needs.
On-demand coordination to arrange confirmatory testing, regulatory-compliant release, and temperature-controlled shipment of stored units to treatment centers or clinical trial sites, including clinical specialist support.
Collection, automated processing, and long-term cryopreservation of newborn cord blood for exclusive family access, with multiple storage-term and payment options and client web-portal account management.
Collection and cryopreservation of cord tissue segments to preserve mesenchymal and other progenitor cell types, including pre-storage viability assessment and integrated storage management with cord blood units.
Optional tiered pediatric genetic testing add-on using mailed buccal swab kits and external CLIA/CAP-certified laboratory analysis. Test tiers provide increasing gene-panel breadth (approximately 250, 600, and 1,500+ genes) and the most comprehensive tier includes pharmacogenetic reporting for 125+ medications. Workflow includes kit activation, portal-based tracking, laboratory sequencing and analysis, and portal delivery of clinical reports; clinical-team support is available for result questions.
Program providing no-cost processing and defined-term storage for families who qualify due to an immediate medical need for a related family member, with operational support for urgent clinical needs.
On-demand coordination to arrange confirmatory testing, regulatory-compliant release, and temperature-controlled shipment of stored units to treatment centers or clinical trial sites, including clinical specialist support.
Expertise Areas
- Newborn stem cell biobanking and long-term cryopreservation
- Automated closed-system processing for hematopoietic cell recovery
- Laboratory information management and client-facing portals for sample tracking and report delivery
- Cold-chain logistics and international courier/customs workflows for biological samples
Key Technologies
- Vapor-phase liquid nitrogen storage
- Automated closed-system cell separation platforms
- Laboratory Information Management Systems (LIMS) with barcode tracking
- Next-generation sequencing (NGS) for targeted gene panels
News & Updates
Reports more than one million cord blood and cord tissue samples stored in long-term cryopreservation.
Reports having released more than 800 cord blood samples for approved transplants and experimental regenerative medicine treatments; released units have been supplied to multiple academic treatment centers and clinical trials.
Publishes a maintained registry of released samples documenting collecting hospital state (including selected international locations), treatment facility, medical condition and category, recipient relationship and age, year of release, and sample storage duration; registry entries document releases to multiple academic and clinical centers and span 2005 through 2025. The public pages also present cumulative release counts and condition-category distributions.
Provides a Chinese-language enrollment page and a dedicated Chinese-language support hotline for client education and enrollment assistance.
Active operational partnerships supplying banked units to multiple FDA-regulated clinical trials and to academic treatment centers for investigational regenerative and transplant uses; public registry entries list treatment facilities and years of release.
Offers tiered pediatric genetic testing via an external CLIA/CAP-certified sequencing laboratory partner, with test options covering approximately 250, 600, and 1,500+ genes and pharmacogenetic reporting for 125+ medications; sample collection is via mailed buccal swab kits and results are delivered through a partner portal with clinical-team support.
Reports more than one million cord blood and cord tissue samples stored in long-term cryopreservation.
Reports having released more than 800 cord blood samples for approved transplants and experimental regenerative medicine treatments; released units have been supplied to multiple academic treatment centers and clinical trials.
Publishes a maintained registry of released samples documenting collecting hospital state (including selected international locations), treatment facility, medical condition and category, recipient relationship and age, year of release, and sample storage duration; registry entries document releases to multiple academic and clinical centers and span 2005 through 2025. The public pages also present cumulative release counts and condition-category distributions.
Provides a Chinese-language enrollment page and a dedicated Chinese-language support hotline for client education and enrollment assistance.
Active operational partnerships supplying banked units to multiple FDA-regulated clinical trials and to academic treatment centers for investigational regenerative and transplant uses; public registry entries list treatment facilities and years of release.
Offers tiered pediatric genetic testing via an external CLIA/CAP-certified sequencing laboratory partner, with test options covering approximately 250, 600, and 1,500+ genes and pharmacogenetic reporting for 125+ medications; sample collection is via mailed buccal swab kits and results are delivered through a partner portal with clinical-team support.